Zyvox Sales Data

Last updated: February 2014 (updated quarterly).
The following data shows Zyvox U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q2 2013 96 (4) -5.18% -9.86%
Q1 2013 92 (5) 11.15% 11.81%
Q4 2012 97 (1) -1.48% -1.55%
Q3 2012 98 (7) -1.37% -8.51%
Q2 2012 91 -3.00% -2.76%
Q1 2012 91 (2) 3.85% 3.57%
Q4 2011 93 (5) 1.17%
Q3 2011 88 (3) -3.78% -9.68%
Q2 2011 91 (9) -4.59% -6.06%
Q1 2011 82

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.

Related News

DateArticle
July 27, 2011FDA MedWatch - Zyvox (linezolid): Drug Safety Communication - Serious CNS Reactions Possible When Given to Patients Taking Certain Psychiatric Medications
Hide
(web4)